UTILE - Intérêt et Usages des anTI-TNF alpha dans la prise en charge du psoriasis de pLaquEs ARCHIVE

Head :
Thibout Emmanuel, Laboratoire Abbott

Last update : 01/01/2019 | Version : 1 | ID : 97

print
Print
xml
XML

Export to XML

Please choose the format :

pdf
PDF
xml
CSV (Excel)

Export to CSV

What sections do you want to export ?

Métadonnées
Identification
General Aspects
Scientific investigator(s) (Contact)
Collaborations
Funding
Governance of the database
Additional contact
Type of database
Database objective
Population type
Dates
Size of the database
Data
Procedures
Promotion
Access
Select all | Invert selection | No selection

Which version do you want to export ?

send
Send
General
Identification
Detailed name Intérêt et Usages des anTI-TNF alpha dans la prise en charge du psoriasis de pLaquEs
Sign or acronym UTILE
CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation CNIL N°1304111
General Aspects
Others (details) plaque psoriasis
Keywords use, liberal dermatology, anti-TNF alpha
Scientific investigator(s) (Contact)
Name of the director Thibout
Surname Emmanuel
Phone +33 (0)1 45 60 13 69
Email emmanuel.thibout@abbott.com
Unit Laboratoire Abbott
Organization Laboratoire
Collaborations
Funding
Funding status Private
Details Abbott France
Governance of the database
Sponsor(s) or organisation(s) responsible Abbott France
Organisation status Private
Additional contact
Main features
Type of database
Type of database Study databases
Study databases (details) Not-repeated cross-sectional studies (except case control studies)
Database recruitment is carried out by an intermediary A selection of health care professionals
Database recruitment is carried out as part of an interventional study No
Additional information regarding sample selection. 400 dermatologist physicians with exclusive liberal exercise or a mixed exercise randomly drawn from a national database
Database objective
Main objective Know the profile of the patients followed for psoriasis
Specify the therapeutic schemas used and in particular the place of biotherapies
Inclusion criteria patients suffering from psoriasis
Population type
Age Adulthood (19 to 24 years)
Adulthood (25 to 44 years)
Adulthood (45 to 64 years)
Population covered Sick population
Gender Male
Woman
Geography area National
Detail of the geography area National
Data collection
Dates
Date of first collection (YYYY or MM/YYYY) 2009
Date of last collection (YYYY or MM/YYYY) 2009
Size of the database
Size of the database (number of individuals) < 500 individuals
Details of the number of individuals 317
Data
Database activity Data collection completed
Type of data collected Clinical data
Clinical data (detail) Direct physical measures
Declarative data (detail) Paper self-questionnaire
Presence of a biobank No
Health parameters studied Health care consumption and services
Care consumption (detail) Medical/paramedical consultation
Medicines consumption
Procedures
Classifications used CIM 10
Participant monitoring No
Links to administrative sources No
Promotion and access
Promotion
Access
Terms of data access (charter for data provision, format of data, availability delay) Report
Access to aggregated data Access on specific project only
Access to individual data Access on specific project only

Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05

View Edit Create here